See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2018_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6848854121920522, 'aggregate_val': 712531000, 'exp_sum': 265386000, 'exp_to_value': {'LiabilitiesCurrent': 246036000, 'LiabilitiesNoncurrent': 19350000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 230,851,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 793,873,000 |
| 2 | PropertyPlantAndEquipmentNet | 13,024,000 |
| 3 | remainder_Assets | 869,000 |
| 4 | LiabilitiesCurrent | 310,580,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 192,973,293 |
| 9 | ResearchAndDevelopmentExpense | 16,962,006 |
| 10 | remainder_Expenses | 212,674,535 |
| 11 | remainder_Revenues | 394,271,579 |
| 12 | remainder_NetIncome | -39,678,721 |
| 13 | remainder_ComprehensiveNetIncome | 19,998 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,038,617,000 |
| 1 | Liabilities | 310,580,000 |
| 2 | Expenses | 422,609,834 |
| 3 | Revenues | 394,271,579 |
| 4 | StockholdersEquity | 728,037,000 |
| 5 | NetIncome | -68,016,976 |
| 6 | ComprehensiveNetIncome | -68,006,977 |
| 7 | BaseVar | 1,102,888,566 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.25 |
| 9 | EconomicCapitalRatio | 3.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
